Advertising

Walsh Medical Media (WMM)�is a new healthcare publishing company dedicated to providing physicians and other healthcare professionals with peer-reviewed publications directly relevant to patient care. The focus of�WMM�publications will be practice-oriented products and services providing clinicians with the latest information and tools needed to improve medical care.

About our Founder, Paul Walsh

WMM�combines decades of publishing/information industry experience with a strong, aggressive entrepreneurial philosophy. Its founder, Paul Walsh, is a publishing veteran with a proven track record in building and managing healthcare information products and services.

Paul is a former Executive Vice President at Thomson Healthcare, where he had overall responsibility for the PDR franchise, as well as Thomson Healthcare�s international business group. His prior industry experience includes senior management positions at Frost & Sullivan and The Research Institute of America.

CS�offers advertisers a unique opportunity to reach a targeted audience of physicians and other healthcare professionals directly involved in the treatment of patients suffering from schizophrenia and related psychoses.

Distributed free to�the 23,642 highest U.S. prescribers�of antipsychotic drug therapies, advertising in�CS�is limited to 6 to 8 ads per issue, providing maximum exposure for our select sponsors. Please click on the link below or the graphic at right to open our complete 2019 Media Planner in PDF format.

Get Our 2019 Media Planner�in PDF�Format.

For information regarding�CS�reprints and advertising opportunities on�www.clinicalschizophrenia.net, contact the publisher.

View Our 2019
Media Planner

paper.io 2

�

Click here to view the latest
�(PDF)

Click here to see the pre-publication
�(PDF)

Click here�to see our�Advertising Material
Specifications.

Click here�to see our�Preprinted Advertising
Insert Specifications.

Click here�to check our�Deadlines schedule.